Description
Several datasets are available (all datasets contain participant ID, randomised allocation, COVID/flu cohort and site):
(1) Main dataset (data collected at all study visits including allocation details, baseline demographics and vaccination details);
(2) Solicited events from electronic participant diaries dataset;
(3) Unsolicited and medically attended events dataset;
(4) Influenza immunogenicity from blood samples dataset (Influenza A H3N2, Influenza A H1N1, Influenza B Victoria, Influenza B Yamagata);
(5) COVID immunogenicity from blood samples dataset (Ig from ECLIA Roche assay, IgG from ELISA Nexelis assay, viral neutralising assay (VNA; neutralisation dilution at 50%, ND50; neutralising factor at 50%, NF50));
(6) COVID immunogenicity from saliva samples dataset (IgG and IgA in binding antibody units (BAU)/ml and normalised OD units)
(1) Main dataset (data collected at all study visits including allocation details, baseline demographics and vaccination details);
(2) Solicited events from electronic participant diaries dataset;
(3) Unsolicited and medically attended events dataset;
(4) Influenza immunogenicity from blood samples dataset (Influenza A H3N2, Influenza A H1N1, Influenza B Victoria, Influenza B Yamagata);
(5) COVID immunogenicity from blood samples dataset (Ig from ECLIA Roche assay, IgG from ELISA Nexelis assay, viral neutralising assay (VNA; neutralisation dilution at 50%, ND50; neutralising factor at 50%, NF50));
(6) COVID immunogenicity from saliva samples dataset (IgG and IgA in binding antibody units (BAU)/ml and normalised OD units)
Date made available | 31 Mar 2023 |
---|---|
Publisher | University of Bristol |
Keywords
- Vaccines
- COVID-19
- Randomised controlled trial
- Immunisation
- Influenza